Menu
Recruiting NCT05848895

OPT-IN: Osteopathic Plagiocephaly Treatment for Infants and Neonates

No phase Interventional Plagiocephaly, Nonsynostotic Plagiocephaly, Positional Plagiocephaly Cranium; Deformity

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Osteopathic Manipulative Treatment, Standard of Care Repositioning.
Who it may be relevant to
Registry conditions: Plagiocephaly, Nonsynostotic, Plagiocephaly, Positional, Plagiocephaly, Cranium; Deformity. Basic parameters: 1 Day — 4 months · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this crossover randomized clinical trial is to assess the effects of osteopathic manipulative treatment (OMT) compared to standard of care repositioning in children diagnosed with positional/deformational plagiocephaly. The main hypothesis is that children who received OMT will show significantly improved anthropometric measures of cranial symmetry over those receiving the current pediatric standard of care of repositioning. This is a two-arm, randomized cross-over clinical trial. With parental consent, pediatric patients (infants \<4 months of age) will be organized into one of two groups: 1. Those who receive OMT with emphasis on osteopathic cranial manipulative medicine (OCMM) to restore cranial symmetry. 2. Those who receive standard care only with repositioning attention from the parents After 8-weeks of being in the first group, each participant will cross-over into the second group (OMT or repositioning) N = 122 subjects diagnosed with deformational plagiocephaly (DP) are to be recruited (to allow for natural attrition and loss to follow up) with the recruitment to continue until 61 patients have been placed in each of the two groups and will cross-over to the respective treatment group (OMT and standard of care repositioning therapy). Timeline: It is projected that to recruit and carry out the assessments and interventions (8-weeks of each group with 12-months of follow-up longitudinally), it will require two years (24-months) from the beginning of the study to completion.

Interventions

  • Procedure Osteopathic Manipulative Treatment
    Osteopathic Manipulative Treatment is a manual treatment therapy applied by licensed physicians that consists of using ones hands to improve the structure and function of the body. In this situation it will involve gentle and passive modalities that are well-tolerated by infants.
  • Behavioral Standard of Care Repositioning
    Parents will receive standardized handouts/materials instructing on repositioning intended to help improve head shape in infants with plagiocephaly.

Primary outcome measures

  • Cranial Vault Asymmetry Index [Time frame: 2 years]
  • Head circumference [Time frame: 2 years]
  • Weight [Time frame: 2 years]
Secondary outcome measures (2)
  • Medical history [Time frame: 12 months]
  • Developmental Milestones [Time frame: 12 months]

Eligibility criteria

Inclusions:

  • Diagnosed with positional plagiocephaly
  • Under 4-months of age (between birth - 4 months) at the time of enrollment

Exclusions:

  • Preterm birth (<37 weeks)
  • Genetic syndromes
  • Craniofacial defects/deformities (e.g. cleft lip/palate)
  • Brachycephaly/scaphocephaly
  • Hypotonia
  • Hypertonia
  • Craniosynostosis
  • Head trauma or other neurological illnesses
  • Lost to follow up
  • Patient whose parents (or legal guardians) disagree to attend 8-treatments of OMT and 2 additional measurement sessions
  • Prior helmet therapy, physical therapy, or OMT before the date of enrollment

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Crossover
Masking
Single blind
Primary purpose
Treatment

Study locations

United States · 1 center
  • Osteopathic Center San Diego — San Diego

Identifiers

NCT: NCT05848895 · OPC001

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗